Construction of a path for optimizing the health management of HBV infections among pregnant and lying-in women based on a Delphi method
ZHOU Yang1, LU Zhaojun2, YAN Rui1, DENG Xuan1, TANG Xuewen1, ZHU Yao1, XU Xiaoping1, HE Hanqing1
1. Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China; 2. Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China
Abstract：Objective To establish an optimized path for health management of HBV infections among pregnant and lying-in women based on a Delphi method, so as to provide the evidence for intensifying the interruption of the mother-to-child transmission of HBV. Methods Based on literature review and previous studies, the preliminary framework and contents of the optimized path for health management of HBV infections were constructed. Experts from epidemiology, clinical medicine and maternal and children healthcare were invited to participate in two-round Delphi consultations, and the preliminarily designed indicators were screened and revised. The score for feasibility of each indicator was calculated, and the weight of each indicator was estimated using a proportional distribution method. Results Sixteen experts participated in the consultation, including 13 women. The participants had a mean age of (45.69±5.71) years, and a mean employment duration of (23.06±7.05) years. All participants had a degree of bachelor and above, and there were 14 experts with vice senior professional titles. The mean positive coefficient was 96.88% and the mean authority coefficient was 0.790 during the two-round expert consultations. There were significant differences in the coordination coefficient of importance, necessity and feasibility of indicators at all levels (P<0.05), and the coefficient of variation of the feasibility was all less than 0.250. The final optimized path for health management of HBV infections among pregnant and lying-in women included 6 primary indicators, 17 secondary indictors and 73 tertiary indicators. Among the primary indicators, delivery management (0.173 4), screening and evaluation (0.172 8) and pregnancy management (0.172 7) had a high weight. Conclusion A scientific and reliable optimized path is created for health management of HBV infections among pregnant and lying-in women, which has a potential value for improving the interruption of mother-to-child transmission of HBV.
周洋, 卢肇骏, 严睿, 邓璇, 唐学雯, 朱瑶, 徐校平, 何寒青. 应用德尔菲法构建乙型肝炎病毒感染孕产妇健康管理优化路径[J]. 预防医学, 2022, 34(6): 631-636.
ZHOU Yang, LU Zhaojun, YAN Rui, DENG Xuan, TANG Xuewen, ZHU Yao, XU Xiaoping, HE Hanqing. Construction of a path for optimizing the health management of HBV infections among pregnant and lying-in women based on a Delphi method. Preventive Medicine, 2022, 34(6): 631-636.
[1] FUNK A L,LU Y,YOSHIDA K,et al.Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus:a systematic review and meta-analysis[J].Lancet Infect Dis,2021,21(1):70-84. [2] 中华医学会妇产科学分会产科学组,中华医学会围产医学分会.乙型肝炎病毒母婴传播预防临床指南(2020)[J].中华妇产科学杂志,2020,55(5):291-299. Chinese Society of Obstetrics and Gynecology,Chinese Society of Perinatal Medicine.Clinical guidelines on prevention of mother-to-child transmission of hepatitis B virus(2020)[J].Chin J Obstet Gynecol,2020,55(5):291-299. [3] 中国肝炎防治基金会,中华医学会感染病学分会,中华医学会肝病学分会.阻断乙型肝炎病毒母婴传播临床管理流程(2021年)[J].临床肝胆病杂志,2021,37(3):527-531. Chinese Foundation for Hepatitis Prevention and Control,Chinese Society of Infectious Diseases,Chinese Society of Hepatology.Management algorithm for prevention of mother-to-child transmission of hepatitis B virus(2021)[J].J Clin Hepatol,2021,37(3):527-531. [4] 刘珏,刘民.我国实现WHO 2030消除乙型肝炎目标的进展与挑战[J].中华流行病学杂志,2019,40(6):605-609. LIU J,LIU M.Progress and challenges in achieving the WHO goal on “Elimination of Hepatitis B by 2030”in China[J].Chin J Epidemiol,2019,40(6):605-609. [5] World Health Organization.Global health sector strategy on viral hepatitis2016-2021[EB/OL].(2016-05-17)[2022-04-21].https://www.who.int/publications/i/item/WHO-HIV-2016.06. [6] 中国肝炎防治基金会,中华医学会感染病学分会,中华医学会肝病学分会.乙型肝炎母婴阻断临床管理流程[J].中华肝脏病杂志,2017,25(4):254-256. Chinese Foundation for Hepatitis Prevention and Control,Chinese Society of Infectious Diseases,Chinese Society of Hepatology.Management algorithm for interrupting of mother-to-child transmission of hepatitis B[J].Chin J Hepatol,2017,25(4):254-256. [7] 中华医学会肝病学分会.感染乙型肝炎病毒的育龄女性临床管理共识[J].中华肝脏病杂志,2018,26(3):204-207. Chinese Society of Hepatology.Consensus on clinical management of hepatitis B virus-infected women of childbearing age[J].Chin J Hepatol,2018,26(3):204-207. [8] 卢肇骏,周洋,郑卫军,等.浙江省试点地区乙型肝炎表面抗原阳性母亲所生新生儿免疫后血清学检测成本调查[J].中国疫苗和免疫,2021,27(6):700-704. LU Z J,ZHOU Y,ZHENG W J,et al.Cost of post-vaccination serologic testing for infants born to hepatitis B surface antigen positive mothers in pilot areas of Zhejiang province[J].Chin J Vaccines Immunization,2021,27(6):700-704. [9] 韦余东,张人杰,张新卫,等.应用德尔菲法构建疾控机构应急能力评价指标体系[J].浙江预防医学,2016,28(1):32-36. WEI Y D,ZHANG R J,ZHANG X W,et al.Using Delphi method to establish evaluation indicator system for the emergency response capability of Centers for Disease Control and Prevention[J].Zhejiang J Prev Med,2016,28(1):32-36. [10] 夏春香,姚明.应用德尔菲法构建HBV感染孕产妇核苷类抗病毒治疗健康教育路径[J].中华现代护理杂志,2016,(22)22:3130-3133. XIA C X,YAO M.On constructing health education path of nucleoside antiviral treatment on pregnant & maternal women with HBV by Delphi method[J].Chin J Mod Nurs, 2016,(22)22:3130-3133. [11] 苗苗,于玲玲,彭博,等.基于STEM构建三级医院院内科研评价指标体系[J].中华医学科研管理杂志,2020,33(4):249-254. MIAO M,YU L L,PENG B,et al.The construction of scientific research evaluation index system based on STEM for the tertiary class A general hospital[J].Chin J Med Sci Res Manage,2020,33(4):249-254. [12] 中华医学会感染病学分会,中华医学会肝病学分会.慢性乙型肝炎防治指南(2019年版)[J].中华传染病杂志,2019,37(12):711-736. Chinese Society of Infectious Diseases,Chinese Society of Hepatology.The guidelines of prevention and treatment for chronic hepatitis B(2019 version)[J].Chin J Infect Dis,2019,37(12):711-736. [13] 杨萍,李秋云,张玉珍,等.新型冠状病毒肺炎疫情期间互联网健康教育模式对乙肝病毒携带产妇产褥期母婴健康的影响[J].北京医学,2021,43(5):472-474. YANG P,LI Q Y,ZHANG Y Z,et al.Influence of Internet health education mode on maternal and infant health of hepatitis B virus carriers during COVID-19 epidemic[J].Beijing Med J,2021,43(5):472-474. [14] 周洋,徐靓亮,雷仙育,等.浙江省产妇乙型肝炎相关知识的知晓率和需求调查[J].中国疫苗和免疫,2020,26(6):694-697. ZHOU Y,XU L L,LEI X Y,et al.Awareness and knowledge needs concerning hepatitis B among women who gave birth in Zhejiang province[J].Chin J Vaccines Immunization,2020,26(6):694-697. [15] ZHOU Y,LU Z,HE H,et al.Influencing factors and necessity of post-vaccination serologic testing follow-up for HBsAg-positive mothers and their infants:a 5-year prospective study in Zhejiang Province,China(2016-2020)[J].J Viral Hepat,2021,28(10):1413-1421. [16] 陈飞,徐放,林殷悦,等.椒江区乙型肝炎病毒母婴传播免疫阻断效果评价[J].预防医学,2021,33(6):634-635. CHEN F,XU F,LIN Y Y,et al.Effect of blocking mother to child transmission of hepatitis B virus by immunization in Jiaojiang District[J].Prev Med,2021,33(6):634-635. [17] LU Z,ZHOU Y,YAN R,et al.Post-vaccination serologic testing of infants born to hepatitis B surface antigen-positive mothers is more cost-effective in Zhejiang Province,China:a Markov chain analysis[J].J Viral Hepat,2022,29(4):280-288. [18] ZHENG H,ZHANG G M,CHAN P L,et al.Compliance among infants exposed to hepatitis B virus in a post-vaccination serological testing program in four provinces in China[J/OL].Infect Dis Poverty,2019,8(57)[2022-04-21].https://doi.org/10.1186/s40249-019-0568-y. [19] 中华人民共和国国家卫生健康委员会.国家免疫规划疫苗儿童免疫程序及说明(2021年版)[J].中国病毒病杂志,2021,11(4):241-245. National Health Commission of the People's Republic of China.Immunization schedules and instructions for vaccines of the national immunization program(2021 version)[J].Chin J Viral Dis,2021,11(4):241-245. [20] 浙江省卫生健康委员会.关于印发浙江省消除艾滋病、梅毒和乙肝母婴传播工作规范(2021年版)的通知[EB/OL].(2021-03-05)[2022-04-21].https://wsjkw.zj.gov.cn/art/2021/3/5/art_1229560650_2320325.html.
